Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Colchicine for Post-AF Ablation Pericarditis Reduction
NCT06731595Phase 2Completed
- Sponsor
- St. Vincent Cardiovascular Research Institute
- Start
- May 2021
- Primary completion
- Jan 2022
- Modality
- Nucleic Acid-Directed Small Molecules, Classical Binding Small Molecules, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in pericarditis comparing Standard of care with Colchicine (2 arms). Primary endpoint: Proportion of patients with Pericarditis at 30 days. Started May 2021; status: completed.
02
Drugs
colchicine
03
Conditions
pericarditis
Beyond the preview
Go deeper on NCT06731595.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06731595.